0001716747-20-000001.txt : 20200520 0001716747-20-000001.hdr.sgml : 20200520 20200519182025 ACCESSION NUMBER: 0001716747-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200520 DATE AS OF CHANGE: 20200519 EFFECTIVENESS DATE: 20200520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nivagen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001716747 IRS NUMBER: 271447740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367343 FILM NUMBER: 20895094 BUSINESS ADDRESS: STREET 1: 3100 FITE CIRCLE STREET 2: SUITE 208 CITY: SACRAMENTO STATE: CA ZIP: 95827 BUSINESS PHONE: 916-364-1662 MAIL ADDRESS: STREET 1: 3100 FITE CIRCLE STREET 2: SUITE 208 CITY: SACRAMENTO STATE: CA ZIP: 95827 D 1 primary_doc.xml X0708 D LIVE 0001716747 Nivagen Pharmaceuticals, Inc. 3050 FITE CIRCLE SUITE 100 SACRAMENTO CA CALIFORNIA 95827 916-364-1662 DELAWARE None None Corporation true Jwalant Shukla 3100 Fite Circle Suite 208 Sacramento CA CALIFORNIA 95827 Executive Officer Director Bikramjit Singh 194 Pleasant Valley Road Morganville NJ NEW JERSEY 07751 Director Ashish Sevak 152 Stuart Street Paramus NJ NEW JERSEY 07652 Director Jaswinder Matharu 7 Hill Street Douglas, Isle of Man X0 UNITED KINGDOM IM1 1EF Director Rob C. Hart 360 Post Street Suite 601 San Francisco CA CALIFORNIA 94108 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-15 false true false 107380 15966462 15966462 0 false 7 0 0 0 false Nivagen Pharmaceuticals, Inc. /s/ Jwalant Shukla Jwalant Shukla President 2020-05-19